skip to main content
Refinado por: Base de dados/Biblioteca: MEDLINE Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal
Material Type:
Artigo
Adicionar ao Meu Espaço

Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal

Montóia, B ; Guerreiro, T ; Viriato, D

Value in health, 2015-11, Vol.18 (7), p.A420-A420 [Periódico revisado por pares]

United States

Texto completo disponível

2
PSS28 - Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal
Material Type:
Artigo
Adicionar ao Meu Espaço

PSS28 - Ranibizumab Vs. Verteporfin Photodynamic Therapy for The Treatment Of Myopic Choroidal Neovascularization: Cost Effectiveness Study In Portugal

Montóia, B ; Guerreiro, T ; Viriato, D

Value in health, 2015-11, Vol.18 (7), p.A420-A420 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

3
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Material Type:
Artigo
Adicionar ao Meu Espaço

Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?

Montóia, B ; Guerreiro, T ; Viana, R

Value in health, 2014-11, Vol.17 (7), p.A395-A395 [Periódico revisado por pares]

United States

Texto completo disponível

4
PND30 - Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Material Type:
Artigo
Adicionar ao Meu Espaço

PND30 - Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?

Montóia, B. ; Guerreiro, T. ; Viana, R.

Value in health, 2014-11, Vol.17 (7), p.A395-A395 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

5
Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective
Material Type:
Artigo
Adicionar ao Meu Espaço

Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

Montóia, B ; Quintino, J ; Castro Sousa, JP ; Amaro, M ; Trindade, F ; Almeida, AS

Value in health, 2016-11, Vol.19 (7), p.A568-A568 [Periódico revisado por pares]

Texto completo disponível

6
PSS38 - Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective
Material Type:
Artigo
Adicionar ao Meu Espaço

PSS38 - Cost-Effectiveness of Ranibizumab Compared to Dexamethasone in Patients with Retinal Vein Occlusion (RVO) from A Portuguese Health Care Perspective

Montóia, B ; Quintino, J ; Castro Sousa, JP ; Amaro, M ; Trindade, F ; Almeida, AS

Value in health, 2016-11, Vol.19 (7), p.A568-A568 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até

Neste Assunto:

  1. Internal Medicine

Buscando em bases de dados remotas. Favor aguardar.